,,ii #aag? ,,congress #a/ ,session ,s4 #cchf ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,decemb] #ad1 #bjba,mr4 ,m55dez 7= himself & ,mr4 ,"y7 introduc$ ! foll[+ bill2 :i* 0 read twice & ref]r$ to ! ,committee on ,=eign ,relations ,a ,,bill ,to prev5t1 treat1 & cure tub]culosis globally4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,end ,tub]culosis ,n[ ,act ( #bjba4 #b4 ,f9d+s ,congress makes ! foll[+ f9d+s3 7#a7 ,m ?an #be ye>s aft] ! ,_w ,heal? ,organization decl>$ ,tub]culosis 7ref]r$ to 9 ?is ,act z ,,tb7 a public heal? em]g5cy & call$ on c\ntries to make scal+ up tub]culosis control a priority1 ,,tb rema9s a deadly heal? ?reat despite ! fact t ,,tb is a prev5table1 treatable1 & curable disease4 7#b7 ,9 #bjai alone1 an e/imat$ #aj1jjj1jjj p became ill ) ,,tb1 #aj p]c5t ( :om 7 *ildr51 & #a1djj1jjj ( :om di$4 ,9 ord] to a*ieve by #bjce ! goals ( ! ,political ,decl>ation ( ! ,high-,level ,meet+ ( ! ,g5]al ,assembly on ! ,fight ,aga9/ ,tub]culosis1 adopt$ by ! ,unit$ ,nations ,g5]al ,assembly ,octob] #aj1 #bjah1 & ( ! ,_w ,heal? ,organization ,end ,,tb ,/rategy1 adopt$ by ! ,_w ,heal? ,assembly 9 #bjad1 new tools mu/ be develop$ & made available4 7#c7 ,ov] #a_/c ( p :o become ill ) ,,tb may be undiagnos$ or misdiagnos$1 result+ 9 unnecess>y illness1 communicable infections1 & increas$ mortality4 7#d7 ,s9ce ,m>* #bjbj1 ! ,,covid-#ai p&emic has sev]ely disrupt$ ,,tb responses 9 l[- & middle-income c\ntries1 /all+ & rev]s+ ye>s ( progress made aga9/ ,,tb1 ) detection dropp+ by #ej p]c5t & an e/imat$ #a1jjj1jjj few] p w be diagnos$ & enroll$ on ,,tb treatm5t4 7#e7 ,9 ,may #bjbj1 a model+ /udy conduct$ by ! ,/op ,tub]culosis ,p>tn]%ip 7ref]r$ to 9 ?is ,act z ! ,/op ,,tb ,p>tn]%ip7 9 collaboration ) ! ,unit$ ,/ates ,ag5cy = ,int]national ,developm5t 7ref]r$ to 9 ?is ,act z ,,usaid7 & p>tn]s e/imat$ t a #c-mon? global lockd[n foll[$ by a protract$ #aj-mon? re/oration c\ld lead to an additional #f1cjj1jjj cases ( ,,tb betwe5 #bjbj & #bjbe & an additional #a1djj1jjj ,,tb dea?s dur+ ?is p]iod1 caus+ a setback ( at lea/ #e to #h ye>s 9 ! fight aga9/ ,,tb4 7#f7 ,f9d+s releas$ by ! ,/op ,,tb ,p>tn]%ip on ,m>* #ah1 #bjba1 f\nd t ,,tb diagnosis & enrolm5t on treatm5t 9 #bjbj decl9$ by an e/imat$ total ( #a1jjj1jjj cases 9 #i c\ntries t collectively repres5t #fj p]c5t ( ! global ,,tb caseload1 pu%+ ! ,,tb response back to #bjjh levels 9 t]ms ( p diagnos$ & treat$4 7#g7 ,failure to prop]ly diagnose & treat ,,tb c lead to dea? & c exac]bate antimicrobial resi/ance1 a key contributor to ris+ cases ( multi-drug-resi/ant tub]culosis1 & ext5sively drug-resi/ant tub]culosis1 & increas+ ! probability ( ! introduction ( resi/ant ,,tb into new geographic areas4 7#h7 ,,tb programs h play$ a c5tral role 9 respond+ to ,,covid-#ai1 includ+ ?r\gh lev]ag+ ! exp]tise ( m$ical /aff ) exp]tise 9 ,,tb & lung diseases1 ! repurpos+ ( ,,tb hospitals1 & ! use ( ! ,,tb rapid molecul> te/+ plat=ms & ,x-,ray equipm5t = multiple purposes1 includ+ ,,covid-#ai4 7#i7 ,) suffici5t res\rc+1 ,,tb program exp]tise1 infection control1 laboratory capacity1 active case f9d+ & contact inve/igation1 c s]ve z a plat=m = respiratory p&emic response aga9/ exi/+ & new infecti\s respiratory disease )\t su* a response necessitat+ ! disruption ( ongo+ ,,tb programs & activities4 7#aj7 ,globally1 only ab\t #a_/b ( ! #ac1jjj1jjj1jjj requir$ annually outl9$ 9 ! ,/op ,,tb ,p>tn]%ip's ,global ,plan to ,end ,,tb = tub]culosis prev5tion1 diagnosis1 & treatm5t is curr5tly available4 7#aa7 ,an e/imat$ additional #c1ejj1jjj1jjj w be ne$$ dur+ #bjba = ,,tb programs 9 c\ntries eligible = ,global ,fund = ,,aids1 ,tub]culosis1 & ,mal>ia programm+ to recov] f ! negative impacts ( ,,covid-#ai1 ) a total annual gap ( at lea/ #h1jjj1jjj1jjj = ,,tb diagnosis1 prev5tion1 & treatm5t 9 su* c\ntries4 7#ab7 ,on ,septemb] #bf1 #bjah1 ! ,unit$ ,nations conv5$ ! fir/ ,high-,level ,meet+ ( ! ,g5]al ,assembly on ! ,fight ,aga9/ ,tub]culosis1 at :i* #abj c\ntries-- 7,a7 sign$ a ,political ,decl>ation to accel]ate progress aga9/ ,,tb1 includ+ commitm5ts to increase fund+ = ,,tb control & rese>* & developm5t programs1 & ambiti\s goals to successfully treat #dj1jjj1jjj p ) tub]culosis & prev5t at lea/ #cj1jjj1jjj f becom+ ill ) ,,tb betwe5 #bjah & #bjbb2 & 7,b7 committ$ to end+ ! epidemic 9 all c\ntries1 & pl$ged to provide lead]%ip & to "w toge!r to accel]ate our national & global collective actions1 inve/m5ts & innovations urg5tly to fight ?is prev5table & treatable disease1 z reflect$ 9 ,unit$ ,nations ,g5]al ,assembly ,resolution ,a_/,,res_/#gc_/c4 7#ac7 ,! ,unit$ ,/ates ,gov]nm5t cont9ues to be a lead fund] ( global ,,tb rese>* & developm5t1 contribut+ #dd p]c5t ( ! total #ija1jjj1jjj 9 global fund+ 9 #bjai1 & c catalyze m inve/m5ts f o!r c\ntries4 7#ad7 ,work+ ) gov]nm5ts & p>tn]s ar\nd ! _w1 ! ,,tb ef=ts by ,,usaid h sav$ #fj1jjj1jjj lives1 demon/rat+ ! effectiv5ess ( ,unit$ ,/ates programs & activities4 7#ae7 ,on ,septemb] #bf1 #bjah1 ! ,,usaid ,adm9i/rator ann\nc$ a new p]=mance-bas$ ,global ,accel]ator to ,end ,,tb1 aim$ at catalyz+ inve/m5ts to meet ! t>get set by ! ,unit$ ,nations ,high-,level ,meet+ on tub]culosis ( treat+ #dj1jjj1jjj p ) ! disease by #bjbb1 fur!r demon/rat+ ! critical role t ,unit$ ,/ates lead]%ip & assi/ance plays 9 ! fight to elim9ate ,,tb4 7#af7 ,x is ess5tial to ensure t ef=ts among ,unit$ ,/ates ,gov]nm5t ag5cies1 p>tn] nations1 int]national organizations1 nongov]nm5tal organizations1 ! private sector1 & o!r actors are complem5t>y & n duplicative 9 ord] to a*ieve ! goal ( end+ ! ,,tb epidemic 9 all c\ntries4 #c4 ,unit$ ,/ates ,gov]nm5t actions to end tub]culosis ,section #ajd;,b ( ! ,=eign ,assi/ance ,act ( #aifa 7#bb ,u4,s4,c4 #baea;b-#c7 is am5d$ to read z foll[s3 #ajd;,b4 ,assi/ance to combat tub]culosis 7a7 ,f9d+s ,congress makes ! foll[+ f9d+s3 7#a7 ,congress recognizes ! cont9u+ *all5ge ( ! int]national spread ( tub]culosis1 & ! deadly impact ( ! cont9u$ exi/5ce ( ,,tb4 7#b7 ,additional tools & res\rces are requir$ to effectively diagnose1 prev5t1 & treat tub]culosis4 7#c7 ,effectively res\rc$ tub]culosis programs c s]ve z a critical plat=m = respiratory p&emic response aga9/ exi/+ & new infecti\s respiratory disease4 7b7 ,policy ,x is a major objective ( ! =eign assi/ance program ( ! ,unit$ ,/ates to help end ! global tub]culosis p&emic ?r\gh actions to support ! diagnosis & treatm5t ( all adults & *ildr5 ) all =ms ( tub]culosis1 & to prev5t new tub]culosis infections 9 adults & *ildr54 ,9 all c\ntries 9 :i* ! ,unit$ ,/ates ,gov]nm5t has e/abli%$ developm5t programs1 p>ticul>ly 9 c\ntries ) ! highe/ burd5 ( tub]culosis & o!r c\ntries ) high rates ( tub]culosis1 x is ! policy ( ! ,unit$ ,/ates-- 7#a7 to support ! objectives ( ! ,_w ,heal? ,organization ,end ,,tb ,/rategy1 includ+ goals-- 7,a7 to r$uce by #ie p]c5t tub]culosis dea?s by #bjce2 7,b7 to r$uce by #ij p]c5t ! tub]culosis incid5ce rate by #bjce2 & 7,c7 to r$uce by #ajj p]c5t ! numb] ( families fac+ cata/rophic heal? co/s due to tub]culosis by #bjce2 7#b7 to support ! ,/op ,,tb ,p>tn]%ip's ,global ,plan to ,end ,,tb #bjah-bjbb1 & any foll[ up plan1 includ+ support =-- 7,a7 develop+ & us+ innovative new te*nologies & !rapies to increase active case f9d+ to rapidly diagnose & treat *ildr5 & adults ) all =ms ( tub]culosis1 alleviate suff]+1 & ensure tub]culosis treatm5t completion2 7,b7 provid+ diagnosis & treatm5t ) ! goal ( successfully treat+ #dj1jjj1jjj p ) tub]culosis by #bjbb1 includ+ #c1ejj1jjj *ildr51 & #a1ejj1jjj p ) drug-resi/ant tub]culosis 9 support ( ! t>get set by ! ,political ,decl>ation ( ! ,high-,level ,meet+ ( ! ,g5]al ,assembly on ! ,fight ,aga9/ ,tub]culosis2 7,c7 diagnos+ & treat+ lat5t tub]culosis infection1 9 support ( ! global goal ( provid+ prev5tive !rapy to at lea/ #cj1jjj1jjj p1 includ+ #d1jjj1jjj *ildr5 "u #e ye>s ( age1 #bj1jjj1jjj h\sehold contacts ( p affect$ by tub]culosis1 & #f1jjj1jjj p liv+ ) ,,hiv1 by #bjbb2 7,d7 ensur+ high quality tub]culosis c>e by clos+ gaps 9 c>e cascades1 implem5t+ cont9u\s quality improvem5t at all levels ( c>e1 & provid+ pati5t support2 & 7,e7 su/a9ably procur+ tub]culosis commodities to avoid int]ruptions 9 supply1 ! procurem5t ( commodities ( unkn[n quality1 or paym5t ( excessive commodity co/s 9 c\ntries impact$ by tub]culosis2 & 7#c7 to ensure t ,unit$ ,/ates fund+ supports activities t simultane\sly emphasize-- 7,a7 ! developm5t ( compreh5sive p]son-c5t]$ programs1 includ+ diagnosis1 treatm5t1 & prev5tion /rategies to ensure t-- 7i7 all p sick ) tub]culosis receive quality diagnosis & treatm5t ?r\gh active case f9d+2 & 7ii7 p at high risk = tub]culosis infection are f\nd & treat$ ) prev5tive !rapies 9 a timely mann]2 7,b7 robu/ tub]culosis infection control practices are implem5t$ 9 all congregate sett+s1 includ+ hospitals & prisons2 7,c7 ! deploym5t ( diagno/ic & treatm5t capacity-- 7i7 9 areas ) ! highe/ tub]culosis burd5s2 & 7ii7 = highly at-risk & impov]i%$ populations1 includ+ pati5t support2 7,d7 program monitor+ & evaluation bas$ on critical tub]culosis indicators1 includ+ indicators relat+ to infection control1 ! numb]s ( pati5ts access+ tub]culosis treatm5t1 along ) pati5t support s]vices1 & prev5tative !rapy = ^? at risk1 includ+ all close contacts1 & treatm5t outcomes = all =ms ( tub]culosis2 7,e7 tra9+ & engagem5t ( heal? c>e work]s on ! use ( new diagno/ic tools & !rapies z !y become available1 & increas$ support = tra9+ frontl9e heal? c>e work]s to support exp&$ tub]culosis active case f9d+1 contact trac+ & pati5t support2 7,f7 coord9ation ) dome/ic ag5cies & organizations on an aggressive rese>* ag5da to develop vacc9es z well z new tools to diagnose1 treat1 & prev5t tub]culosis globally2 7,g7 l9kages ) ! private sector on-- 7i7 rese>* & developm5t ( a vacc9e1 & on new tools = diagnosis & treatm5t ( tub]culosis2 7ii7 improv+ curr5t tools = diagnosis & treatm5t ( tub]culosis2 & 7iii7 tra9+ heal?c>e pr(essionals on use ( ! newe/ & mo/ effective diagno/ic & !rapeutic tools2 7,h7 ! r$uction ( b>ri]s to c>e1 includ+ /igma & treatm5t & diagnosis co/s1 ?r\gh-- 7i7 tra9+ = heal? work]s2 7ii7 s5sitiz+ ( policy mak]s2 7iii7 requirem5ts = access & af=dability provisions 9 all grants & fund+ agreem5ts2 7iv7 education & emp[]m5t campaigns = tub]culosis pati5ts reg>d+ local tub]culosis s]vices2 7v7 monitor+ b>ri]s to access+ tub]culosis s]vices2 & 7vi7 increas$ support = pati5t-l$ & community-l$ tub]culosis outrea* ef=ts2 & 7,i7 support = c\ntry-level1 su/a9able acc\ntability me*anisms & capacity to measure progress & ensure t commitm5ts made by gov]nm5ts & relevant /akehold]s are met4 7c7 ,def9itions ,9 ?is section3 7#a7 ,appropriate congressional committees ,! t]m appropriate congressional committees means ! ,committee on ,=eign ,relations ( ! ,s5ate & ! ,committee on ,=eign ,affairs ( ! ,h\se ( ,repres5tatives4 7#b7 ,end ,,tb /rategy ,! t]m ,end ,,tb ,/rategy means ! /rategy to elim9ate tub]culosis t 0 approv$ by ! ,_w ,heal? ,assembly 9 ,may #bjad1 & is describ$ 9 ,! ,end ,,tb ,/rategy3 ,global /rategy & t>gets = tub]culosis prev5tion1 c>e & control aft] #bjae4 7#c7 ,global alliance = tub]culosis drug developm5t ,! t]m ,global ,alliance = ,tub]culosis ,drug ,developm5t means ! public-private p>tn]%ip t br+ toge!r lead]s 9 heal?1 sci5ce1 philan?ropy1 & private indu/ry to devise new approa*es to tub]culosis4 7#d7 ,global tub]culosis drug facility ,! t]m ,global ,tub]culosis ,drug ,facility means ! initiative ( ! ,/op ,tub]culosis ,p>tn]%ip to increase access to ! mo/ advanc$1 af=dable1 quality-assur$ tub]culosis drugs & diagno/ics4 7#e7 ,,mdr-,,tb ,! t]m ,,mdr-,,tb means multi-drug-resi/ant tub]culosis4 7#f7 ,/op tub]culosis p>tn]%ip ,! t]m ,/op ,tub]culosis ,p>tn]%ip means ! p>tn]%ip ( ! ,unit$ ,nations ,(fice = ,project ,s]vices1 donors includ+ ! ,unit$ ,/ates1 high tub]culosis burd5 c\ntries1 multilat]al ag5cies1 & nongov]nm5tal & te*nical ag5cies committ$ to %ort- & long-t]m measures requir$ to control & ev5tually elim9ate tub]culosis z a public heal? problem 9 ! _w4 7#g7 ,,xdr-,,tb ,! t]m ,,xdr-,,tb means ext5sively drug-resi/ant tub]culosis4 7d7 ,au?orization ,to c>ry out ?is section1 ! ,presid5t is au?oriz$1 consi/5t ) section #ajd7;c71 to furni% assi/ance1 on su* t]ms & conditions z ! ,presid5t may det]m9e1 = ! prev5tion1 treatm5t1 control1 & elim9ation ( tub]culosis4 7e7 ,goals ,9 consultation ) ! appropriate congressional committees1 ! ,presid5t %all e/abli% goals1 bas$ on ! policy & indicators describ$ 9 subsection 7b71 = ,unit$ ,/ates tub]culosis programs to detect1 cure & prev5t all =ms ( tub]culosis globally = ! p]iod betwe5 #bjbc & #bjcj t is align$ ) ! ,end ,,tb ,/rategy's #bjcj t>gets1 by updat+ ! ,unit$ ,/ates ,gov]nm5t ,tub]culosis ,/rategy 7#bjae-bjai7 & ! ,national ,action ,plan = ,combat+ ,multidrug-,resi/ant ,tub]culosis4 7f7 ,coord9ation 7#a7 ,9 g5]al ,9 c>ry+ out ?is section1 ! ,presid5t %all coord9ate ) ! ,_w ,heal? ,organization1 ! ,/op ,,tb ,p>tn]%ip1 ! ,global ,fund to ,fight ,,aids1 ,tub]culosis1 & ,mal>ia1 & o!r organizations ) respect to ! developm5t & implem5tation ( a compreh5sive global tub]culosis response program4 7#b7 ,bilat]al assi/ance ,9 provid+ bilat]al assi/ance "u ?is section1 ! ,presid5t1 act+ ?r\gh ! ,adm9i/rator ( ! ,unit$ ,/ates ,ag5cy = ,int]national ,developm5t1 %all-- 7,a7 catalyze support = rese>* & developm5t ( new tools to prev5t1 diagnose1 treat1 & control tub]culosis worldwide1 p>ticul>ly to r$uce ! incid5ce (1 & mortality f1 all =ms ( drug-resi/ant tub]culosis2 7,b7 ensure ,unit$ ,/ates programs & activities aim$ at rea*+ ^? infect$ ) tub]culosis provide quality diagnosis & treatm5t1 & rea* ^? at high risk ) prev5tive !rapy2 & 7,c7 ensure coord9ation among relevant ,unit$ ,/ates ,gov]nm5t ag5cies1 includ+ ! ,c5t]s = ,disease ,control & ,prev5tion1 ! ,national ,in/itutes ( ,heal?1 ! ,biom$ical ,advanc$ ,rese>* & ,developm5t ,au?ority1 ! ,food & ,drug ,adm9i/ration1 ! ,national ,sci5ce ,f\ndation1 ! ,dep>tm5t ( ,def5se 7?r\gh its ,congressionally ,direct$ ,m$ical ,rese>* ,program71 & o!r ,f$]al ag5cies t engage 9 int]national tub]culosis activities to ensure acc\ntability & transp>5cy1 r$uce duplication ( ef=ts & ensure appropriate integration & coord9ation ( tub]culosis s]vices into o!r ,unit$ ,/ates-support$ heal? programs4 7g7 ,priority ,to ,end ,,tb ,/rategy ,9 furni%+ assi/ance "u subsection 7d71 ! ,presid5t %all give priority to-- 7#a7 build+ & /r5g!n+ tub]culosis programs to diagnose & treat all p sick ) ,,tb1 & ensur+ ev]yone :o is sick ) tub]culosis h access to quality diagnosis & treatm5t2 7#b7 direct1 high-quality integrat$ s]vices = all =ms ( tub]culosis1 z describ$ by ! ,_w ,heal? ,organization1 :i* call = ! coord9ation ( active case f9d+1 treatm5t ( all =ms ( tub]culosis disease & infection1 pati5t support1 & tub]culosis prev5tion2 7#c7 individuals co-infect$ ) ,,hiv & o!r co-morbidities1 & o!r individuals ) tub]culosis :o may be at risk ( /igma2 7#d7 /r5g!n+ ! capacity ( heal? sy/ems to detect1 prev5t1 & treat tub]culosis1 includ+ ,,mdr-,,tb & ,,xdr-,,tb1 z describ$ 9 ! ,int]national ,/&>ds = ,tub]culosis ,c>e1 & ! late/ int]national guidance relat$ to tub]culosis2 7#e7 rese>* & developm5t ( innovative diagno/ics1 drug !rapies1 & vacc9es1 & program-bas$ op]ational rese>*2 7#f7 ! ,/op ,tub]culosis ,p>tn]%ip's ,global ,drug ,facility1 & ! ,global ,alliance = ,tub]culosis ,drug ,developm5t1 & o!r organizations promot+ ! developm5t ( new products & drugs = tub]culosis2 & 7#g7 ensur+ tub]culosis programs c s]ve z key plat=ms = support+ national respiratory p&emic response aga9/ exi/+ & new infecti\s respiratory disease4 7h7 ,assi/ance = ! ,_w ,heal? ,organization & ! ,/op ,tub]culosis ,p>tn]%ip ,9 c>ry+ out ?is section1 ! ,presid5t1 act+ ?r\gh ! ,adm9i/rator ( ! ,unit$ ,/ates ,ag5cy = ,int]national ,developm5t1 is au?oriz$ to provide increas$ res\rces to ! ,_w ,heal? ,organization & ! ,/op ,tub]culosis ,p>tn]%ip to improve ! capacity ( c\ntries ) high burd5s or rates ( tub]culosis & o!r affect$ c\ntries to implem5t ! ,end ,,tb ,/rategy1 ! ,/op ,,tb ,global ,plan to ,end ,,tb1 _! own national /rategies & plans1 o!r global ef=ts to control ,,mdr-,,tb & ,,xdr-,,tb4 7i7 ,annual report on tub]culosis activities ,n lat] ?an ,decemb] #ae ( ea* ye> until ! goals specifi$ 9 subsection 7b77#a7 are met1 ! ,presid5t %all submit an annual report to ! appropriate congressional committees t describes ,unit$ ,/ates =eign assi/ance to control tub]culosis & ! impact ( su* ef=ts1 includ+-- 7#a7 ! numb] ( individuals ) active tub]culosis disease t 7 diagnos$ & treat$1 includ+ ! rate ( treatm5t completion & ! numb] receiv+ pati5t support2 7#b7 ! numb] ( p]sons ) ,,mdr-,,tb & ,,xdr-,,tb t 7 diagnos$ & treat$1 includ+ ! rate ( completion1 9 c\ntries receiv+ ,unit$ ,/ates bilat]al =eign assi/ance = tub]culosis control programs2 7#c7 ! numb]s ( p tra9$ by ! ,unit$ ,/ates ,gov]nm5t 9 tub]culosis surveillance & control2 7#d7 ! numb] ( individuals ) active ,,tb disease id5tifi$ z a result ( engagem5t ) ! private sector & o!r nongov]nm5tal p>tn]s 9 c\ntries receiv+ ,unit$ ,/ates bilat]al =eign assi/ance = tub]culosis control programs2 7#e7 a description ( ! collaboration & coord9ation ( ,unit$ ,/ates anti-tub]culosis ef=ts ) ! ,_w ,heal? ,organization1 ! ,/op ,,tb ,p>tn]%ip1 ! ,global ,fund to ,fight ,,aids1 ,tub]culosis & ,mal>ia1 & o!r major public & private entities2 7#f7 a description ( ! collaboration & coord9ation among ! ,unit$ ,/ates ,ag5cy = ,int]national ,developm5t & o!r ,unit$ ,/ates ag5cies1 includ+ ! ,c5t]s = ,disease ,control & ,prev5tion & ! ,(fice ( ! ,global ,,aids ,coord9ator1 = ! purposes ( combat+ tub]culosis2 7#g7 ! con/ra9ts on implem5tation ( programs pos$ by heal? work=ce %ortages1 heal? sy/em limitations1 o!r compon5ts ( successful implem5tation1 & /rategies to address su* con/ra9ts2 7#h7 a breakd[n ( exp5ditures = pati5t s]vices support+ ,,tb diagnosis1 treatm5t1 & prev5tion1 includ+ procurem5t ( drugs & o!r commodities1 drug managem5t1 tra9+ 9 diagnosis & treatm5t1 heal? sy/ems /r5g!n+ t directly impacts provision ( ,,tb s]vices1 & rese>*2 & 7#i7 = ea* c\ntry receiv+ bilat]al ,unit$ ,/ates assi/ance = ! purpose ( tub]culosis prev5tion1 treatm5t1 & control-- 7,a7 a description ( progress to adopt & implem5t ! mo/ rec5t ,_w ,heal? ,organization guidel9es to improve diagnosis1 treatm5t1 & prev5tion ( tub]culosis = adults & *ildr51 disaggregat$ by sex1 includ+ ! proportion ( heal? facilities t h adopt$ ! late/ ,_w ,heal? ,organization guidel9es on /r5g!n+ surveillance sy/ems & prev5tative1 diagno/ic1 & !rapeutic me?ods1 includ+ ! use ( rapid diagno/ic te/s & orally adm9i/]$ tub]culosis treatm5t regim5s2 7,b7 ! numb] ( adults & *ildr5 receiv+ tub]culosis prev5tive !rapy1 includ+ p ) ,,hiv & all close contacts1 disaggregat$ by sex &1 z possible1 income or weal? qu9tile1 & ! e/abli%m5t ( effective tub]culosis infection control 9 all relevant congregant sett+s1 includ+ hospitals1 cl9ics1 & prisons2 7,c7 a description ( progress 9 implem5t+ measures to r$uce tub]culosis incid5ce1 includ+ actions-- 7i7 to exp& active case f9d+ & contact trac+ to id5tify & rea* vuln]able gr\ps2 & 7ii7 to exp& tub]culosis prev5tive !rapy1 engagem5t ( ! private sector1 & diagno/ic capacity2 7,d7 a description ( progress to exp& diagnosis1 prev5tion1 & treatm5t = all =ms ( tub]culosis1 includ+ 9 pregnant wom51 *ildr51 & o!r high-risk individuals & gr\ps at great] risk ( ,,tb1 includ+ migrants1 prison]s1 m9]s1 p expos$ to silica1 & p liv+ ) ,,hiv_/,,aids1 disaggregat$ by sex2 7,e7 ! rate ( successful completion ( tub]culosis treatm5t = adults & *ildr51 disaggregat$ by sex1 & ! numb] ( individuals receiv+ support = treatm5t completion2 7,f7 ! numb] ( p1 disaggregat$ by sex1 receiv+ treatm5t = ,,mdr-,,tb1 ! proportion ( ^? treat$ ) ! late/ regim5s endors$ by ! ,_w ,heal? ,organization1 any factors imp$+ scale up ( su* treatm5t1 & a description ( progress to exp& community-bas$ ,,mdr-,,tb c>e2 7,g7 a description ( tub]culosis commodity procurem5t *all5ges1 includ+ %ortages1 /ock\ts1 or fail$ t5d]s = tub]culosis drugs or o!r commodities2 7,h7 ! proportion ( heal? facilities ) specim5 ref]ral l9kages to ,gene,xpert te/+ sites1 & to ref]5ce labs = second l9e drug resi/ance te/+1 & a description ( ! turn>\nd "t = te/ results2 7,i7 ! numb] ( p tra9$ by ! ,unit$ ,/ates ,gov]nm5t to deliv] high-quality tub]culosis surveillance1 laboratory s]vices1 prev5tion1 treatm5t1 & c>e2 7,j7 a description ( h[ support$ activities are coord9at$ )-- 7i7 c\ntry national ,,tb plans & /rategies2 & 7ii7 tub]culosis control ef=ts support$ by ! ,global ,fund to ,fight ,,aids1 ,tub]culosis1 & ,mal>ia1 & o!r int]national assi/ance funds1 includ+ 9 ! areas ( program developm5t & implem5tation2 & 7,k7 = ! fir/ #c ye>s ( ! report requir$ "u ?is subsection1 a section t describes ! progress 9 recov]+ f ! negative impact ( ,,covid-#ai on tub]culosis1 includ+ :e!r !re has be5 ! developm5t & implem5tation ( a compreh5sive plan to ensure tub]culosis activities recov] f div]sion ( res\rces1 ! cont9u$ use ( bidirectional ,,tb-,,covid te/+1 & progress on increas$ diagnosis & treatm5t ( active tub]culosis4 7j7 ,annual report on tub]culosis rese>* & developm5t ,! ,presid5t1 act+ ?r\gh ! ,adm9i/rator ( ! ,unit$ ,/ates ,ag5cy = ,int]national ,developm5t1 & 9 coord9ation ) ! ,national ,in/itutes ( ,heal?1 ! ,c5t]s = ,disease ,control & ,prev5tion1 ! ,biom$ical ,advanc$ ,rese>* & ,developm5t ,au?ority1 ! ,food & ,drug ,adm9i/ration1 ! ,national ,sci5ce ,f\ndation1 & ! ,(fice ( ! ,global ,,aids ,coord9ator1 %all submit an annual report to ,congress t-- 7#a7 describes curr5t progress & *all5ges to ! developm5t ( new tools = ! purpose ( tub]culosis prev5tion1 treatm5t1 & control2 7#b7 id5tifies critical gaps & em]g+ priorities = rese>* & developm5t1 includ+ = rapid & po9t-(-c>e diagno/ics1 %ort5$ treatm5ts & prev5tion me?ods1 & vacc9es2 & 7#c7 describes rese>* inve/m5ts by type1 fund$ entities1 & level ( inve/m5t4 7k7 ,evaluation report ,n lat] ?an #b ye>s aft] ! date ( ! enactm5t ( ! ,end ,tub]culosis ,n[ ,act ( #bjba1 & e #e ye>s !reaft] until #bjcf1 ! ,comptroll] ,g5]al ( ! ,unit$ ,/ates %all submit a report to ! appropriate congressional committees t evaluates ! p]=mance & impact on tub]culosis prev5tion1 diagnosis1 treatm5t1 & c>e ef=ts t are support$ by ,unit$ ,/ates bilat]al assi/ance fund+1 includ+ recomm5dations = improv+ su* programs4 4